Epidemiology of prostate cancer: Recent results from the Epidemiological Cancer Register of the District of Münster (Germany);Aktuelle daten zur epidemiologie des prostatakarzinoms: Ergebnisse aus dem regierungsbezirk Münster

Urologe - Ausgabe A

Volumn 47, Issue 7, 2008, Pages 853-859

  Kraywinkel, K ^a,c   Lehnert, M ^a   Semjonow, A ^b   Hense, H W ^a,b  

^a Epidemiologisches Krebsregister NRW   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Epidemiology; Incidence; Mortality; Prostate cancer; Survival

Indexed keywords

ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER INCIDENCE; CANCER INFILTRATION; CANCER MORTALITY; CANCER REGISTRY; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROSTATE CANCER;

GERMANY; HUMANS; INCIDENCE; MALE; PROSTATIC NEOPLASMS; REGISTRIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 46949089576     PISSN: 03402592     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00120-008-1691-8     Document Type: Article

References (36)

1. American Cancer Society (2007) Cancer Facts And Figures 2007. Verfügbar unter http://www.cancer.org/downloads/STT/CAFF2007PWSecured.pdf (letzter Zugriff: 31.07.2007). American Cancer Society, New York
2. Amsterdam Cancer Registry (2007) Relative survival of cancer patients in North-Holland/Flevoland. Verfügbar unter http://www.ikcnet.nl/uploaded/ FILES/IKA/kankerregistratie/overleving/9.xls#'61'!A1 (letzter Zugriff: 31.7.2007). Amsterdam Cancer Registry, Amsterdam
3. Association of Nordic Cancer Registries (2007) NORDCAN: Cancer inicdence and mortality in the Nordic Countries. Verfügbar unter http://www-dep.iarc. fr/NORDCAN/english/frame.asp (letzter Zugriff: 31.07.2007). Association of Nordic Cancer Registries, Oslo
4. Baade PD, Coory MD, Aitken JF (2004) International trends in prostate-cancer mortality: the decrease is continuing and spreading. Cancer Causes Control 15: 237-241
5. Brenner H, Arndt V (2005) Long-term survival rates of patients with prostate cancer in the prostate-specific antigen screening era: Population-based estimates for the year 2000 by period analysis. J Clin Oncol 23: 441-447
6. Brenner H, Gefeller O (1996) An alternative approach to monitoring cancer patient survival. Cancer 78: 2004-2010
7. Brenner H, Hakulinen T (2002) Up-to-date long-term survival curves of patients with cancer by period analysis. J Clin Oncol 20: 826-832
8. Brenner H, Soderman B, Hakulinen T (2002) Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370 000 cancer patients in Finland. Int J Epidemiol 31: 456-462
9. Brenner H, Stegmaier C, Ziegler H (2005) Long-term survival of cancer patients in Germany achieved by the beginning of the third millenium. Ann Oncol 16: 981-986
10. Cancer Research UK (2007) Prostate Cancer survival statistics. Verfügbar unter http://info.cancerresearchuk.org/cancerstats/types/ prostate/survival/?a=5441 (letzter Zugriff: 31.07.2007). Cancer Research UK, London
11. Coleman MP, Gatta G, Verdecchia A et al. the EUROCARE Working Group (2003) EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol 14: v128-v149
12. Crawford ED (2003) Epidemiology of prostate cancer. Urology 62: 3-12
13. Koning HJ de, Auvinen A, Sanchez AB et al. (2002) Large-scale randomized prostate cancer screening trials: Program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial. Int J Cancer 97: 237-244
14. Epidemiologisches Krebsregister Niedersachsen (2003) Jahresbericht 'Krebs in Niedersachsen 20003'. Verfügbar unter http://www.krebsregister- niedersachsen.de/registerstelle/dateien/Jahresbericht_2003.pdf (letzter Zugriff: 31.07.2007). Epidemiologisches Krebsregister Niedersachsen, Hannover
15. Epidemiologisches Krebsregister Saarland (2007) Datenbankabfrage. Verfügbar unter http://www.krebsregister.saarland.de/datenbank/datenbank. html (letzter Zugriff: 31.07.2007). Epidemiologisches Krebsregister Saarland, Saarbrücken
16. Ferlay J, Autier P, Boniol M et al. (2007) Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 18: 581-592
17. Finish Cancer Registry (2003) Cancer in Finland 2002/2003. Verfügbar unter http://www.cancerregistry.fi/eng/statistics/index_7.pdf (letzter Zugriff: 31.07.2007). Finish Cancer Registry, Helsinki
18. Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. in Zusammenarbeit mit dem Robert-Koch-Institut. Krebs in Deutschland. Verfügbar unter http://www.ekr.med.uni-erlangen.de/GEKID/Doc/kid2006.pdf (letzter Zugriff: 31.07.2007). Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V., Lübeck
19. Gondos A, Arndt V, Holleczek B et al. (2007) Cancer survival in Germany and the United States at the beginning of the 21st century: An up-to-date comparison by period analysis. Int J Cancer 121: 395-400
20. Hakulinen T (1982) Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics 38: 933-942
21. Hamburgisches Krebsregister (2007) Datenbankabfrage. Verfügbar unter http://www.krebsregister-hamburg.de/ (letzter Zugriff: 31.07.2007). Hamburgisches Krebsregister, Hamburg
22. Hayat MJ, Howlader N, Reichman ME, Edwards BK (2007) Cancer statistics, trends, and multiple primary cancer analyses from the surveillance, epidemiology, and end results (SEER) program. Oncologist 12: 20-37
23. Institut für Krebsepidemiologie e.V. (2004) Jahresbericht: "Krebs in Schleswig-Holstein - Band 6 - Inzidenz und Mortalität im Jahr 2004". Verfügbar unter http://www.krebsregister-sh.de/berichte/ kish2004high.pdf (letzter Zugriff: 31.07.2007). Institut für Krebsepidemiologie e.V., Lübeck
24. Krebsregister Schleswig-Holstein (2007) Datenbankabfrage. Verfügbar unter http: //www.krebsregister-sh.de/datenbank/index.php. Letzter Zugriff: 31.7.2007. Krebsregister Schleswig-Holstein, Lübeck
25. National Statistics UK (2003) Cancer Registration Statistics 2002/03. Verfügbar unter http://www.statistics.gov.uk/statbase/Product.asp?vlnk= 8843&More=N (letzter Zugriff: 31.07.2007). National Statistics UK, London
26. Oliver SE, May MT, Gunnell D (2001) International trends in prostate-cancer mortality in the.,PSA ERA". Int J Cancer 92: 893-898
27. Quinn M, Babb P (2002) Patterns and trends in prostate cancer incidence, survival, prevalence and mortality. Part II: individual countries. BJU Int 90: 174-184
28. Statistical Research and Application Branch, National Cancer Institute. DevCan: Probability of Developing or Dying of Cancer Software, version 6.1.1. Verfügbar unter http://www.srab.cancer.gov/devcan (letzter Zugriff: 31.07.2007). Statistical Research and Application Branch, National Cancer Institute, Bethesda, MD, USA
29. Surveillance, Epidemiology and End Results SEER Program. SEER Incidence Statistics. Verfügbar unter http://www.seer.cancer.gov/canques/incidence. html (letzter Zugriff: 31.07.2007). Surveillance, Epidemiology and End Results SEER Program, Bethesda, MD, USA
30. Talback M, Rosen M, Stenbeck M, Dickman PW (2004) Cancer patient survival in Sweden at the beginning of the third millennium - predictions using period analysis. Cancer Causes Control 15: 967-976
31. Talback M, Stenbeck M, Rosen M (2004) Up-to-date long-term survival of cancer patients: an evaluation of period analysis on Swedish Cancer Registry data. Eur J Cancer 40: 1361-1372
32. Tumorregister München. Jahresbericht 2000 des klinisch- epidemiologischen Krebsregisters am Tumorzentrum München. Verfügbar unter http://www.tumorregister-muenchen.de/annals/j2000.html (letzter Zugriff: 31.07.2007). Tumorregister, München
33. Tumorregister Tirol. Bericht für das Diagnosejahr 2003. Verfügbar unter http://www.iet.at/fileadmin/iet/files/tumorregister/ trt_bericht_2003.pdf (letzter Zugriff: 31.07.2007). Tumorregister, Tirol
34. Vutuc C, Schernhammer ES, Haidinger G, Waldhor T (2005) Prostate cancer and prostate specific antigen (PSA) screening in Austria. Wien Klin Wochenschr 117: 457-461
35. Welch HG, Schwartz LM, Woloshin S (2000) Are increasing 5-year survival rates evidence of success against cancer? JAMA 283: 2975-2978
36. Wittekind C, Meyer HJ, Bootz F (2002) TNM Klassifikation maligner Tumoren. Springer, Berlin Heidelberg New York, S 172-175